Applied DNA Sciences Schedules Fiscal 2016 First Quarter Conference Call and Webcast for February 10, 2016 at 4:30 pm ET

STONY BROOK, NY -- (Marketwired) -- 01/28/16 --

Applied DNA Sciences (NASDAQ: APDN) (Twitter: @APDN), a provider of DNA-based supply-chain, anti-counterfeiting and anti-theft technology, product genotyping and product authentication solutions, will host a conference call and webcast on Wednesday, February 10, 2016 at 4:30 PM ET to discuss its fiscal 2016 first quarter results.

Dr. James Hayward, President and CEO, and Beth Jantzen, CFO, of Applied DNA Sciences, plan to discuss the company's performance and achievements for the quarter and outline key ongoing business initiatives for the 2016 fiscal year. The presentation will be followed by a question-and-answer session.

All participants to the conference call must pre-register using the link below. Due to the large number of expected participants, not all questions may be answered on the call.

For those investors unable to attend the live call, a copy of the presentation is expected to be posted shortly after the conclusion of the live call and will be available under the "Investor Information" tab of the company's web site. Conference call and webcast replay information is provided below.

To Participate:

Reserve your conference call seat now at: http://dpregister.com/10079875. Conference call dial-in information will be provided at completion of the registration process.

Live webcast: http://services.choruscall.com/links/apdn160202

Replay (available 1 hour following the conclusion of the live call):

• Participant Toll Free: 877-344-7529
• Participant Toll: 412-317-0088
• Participant Passcode: 10079875
• Webcast replay: http://services.choruscall.com/links/apdn160202

About Applied DNA Sciences

Applied DNA Sciences makes life real and safe by providing biotechnology-driven solutions to help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. Patented botanical DNA solutions can be used to identify, tag, track, and trace products, to help assure authenticity, traceability and quality of products. SigNature DNA is at the heart of a family of uncopyable, security and authentication solutions such as SigNature® T and fiberTyping®, for textiles and apparel, DNAnet®, for anti-theft and loss prevention, and digitalDNA®, providing powerful track and trace. All provide a forensic chain of evidence, and can be used to prosecute perpetrators. Go to adnas.com for more information, events and to learn more about how Applied DNA Sciences makes life real and safe. Common stock listed on NASDAQ under the symbol APDN, and warrants are listed under the symbol APDNW.

Forward Looking Statements

The statements made by APDN in this press release may be "forward-looking" in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe APDN's future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN's SEC reports and filings, including our Annual Report on Form 10-K filed on December 14, 2015, which is available at www.sec.gov. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.

   
    investor contact: Debbie [email protected] contact: Susan FormanDian Griesel Int'[email protected]: www.adnas.comtwitter: @APDN

Source: Applied DNA Sciences

You May Also Be Interested In

• Trump Media & Technology (DJT) Declines 17% on Concerns Stockholders May Sell Shares
• Trump Media & Technology Group (DJT) stock falls as it files to sell shares
• Crypto VC inflows 'look rather subdued' says JPMorgan